Diabetes
Latest News
Triple Therapy May Be Effective in Drug-Naive T2D
Combo of metformin, dapagliflozin, and saxagliptin could reduce body weight and adverse events, compared with step-wise therapy.
Latest News
Exercise Plus GLP-1 RAs Upped Weight Loss, Bone Retention
Study finds combination of GLP-1 RAs and exercise increased weight loss and maintained bone health.
Latest News
Does Semaglutide Reduce Inflammation?
Study finds an association between semaglutide and reduced inflammatory marker levels; implications are yet unknown.
Latest News
Pancreatic Gene Therapy: A ‘One-and-Done’ GLP-1 Treatment?
A single-dose pancreatic gene therapy may compare with GLP-1 effect, a mouse model study finds.
Latest News
Compounded Semaglutide: How to Better Ensure Its Safety
Ask questions about the pharmacy and, if possible, interview the pharmacist about certifications and procedures.
Latest News
Ghrelin Paradox: Unlocking New Avenues in Obesity Management
The hunger hormone’s role in appetite and weight gain may be an option for weight management as researchers look to therapeutic modulation.
Latest News
Tirzepatide Reduces Sleep Interruptions, Halting Almost Half of CPAP Use
Similar to other GLP-1s, tirzepatide, has been found to reduce sleep interruptions in patients with OSA and obesity.
Latest News
Intermittent Fasting Tops Calorie Restriction for Gut Health
Study finds intermittent-fasting, protein-pacing diet improved gut microbiota better than Mediterranean diet.
From the Journals
Metformin Gets a Reproductive Reprieve — For Diabetic Moms and Dads Alike
Physicians can reassure parents with diabetes about the safety of metformin use before conception and in early pregnancy.
Latest News
Metabolic Health Tied to Lower Prediabetes Risk
Compared with those in the metabolically healthy normal-weight group, the odds of prediabetes were at least two times higher in the metabolically...
Latest News
More and More Are Living With Type 1 Diabetes Into Old Age
Mortality and disability-adjusted life years (DALYs) among people with type 1 diabetes aged ≥ 65 years dropped significantly from 1990 to 2019.